Our client was one of the world’s largest pharmaceutical companies. It is widely known for its large consumer healthcare division that produces household-name oral healthcare and nutritional products, drinks and over-the-counter medicines. It also has a portfolio of products for major disease areas such as asthma, cancer, virus control, infections, mental health, diabetes and digestive conditions.
Our client was keen to develop its nutritional product offering, with a focus on nutraceutical products (a food or food product that provides health and medical benefits). The company’s management team identified a need to build a more in-depth understanding of the scale and addressability of opportunities within this market in order to better focus its strategy. We were engaged to map the market and identify potential growth areas.
“CIL exceeded our expectations as far as the opportunities part of the work was concerned; all the supporting spreadsheets were brilliant. I would definitely recommend CIL and have done already” – pharmaceutical client
We conducted research into the UK nutritional market to help inform our client’s market entry strategy within the nutraceutical sector. Key areas covered were:
- Segmentation of products
- Consumer needs
- Claims of the products in the market (purposes, functions, claimed benefits for consumers etc.)
- Competitive offering and market shares
- Understanding what other non-product / activity based solutions are available to consumers.
Our report and presentation to management identified a number of new opportunities and their relative attractiveness. Our recommendations proved highly valuable for developing the company’s nutritional products strategy.